These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9714639)

  • 1. Reducing inappropriate oral antibiotic use: a prescription for change.
    Bauchner H; Philipp B
    Pediatrics; 1998 Jul; 102(1 Pt 1):142-5. PubMed ID: 9714639
    [No Abstract]   [Full Text] [Related]  

  • 2. Resisting the urge to prescribe.
    Edwards KM
    J Pediatr; 1996 Jun; 128(6):729-30. PubMed ID: 8648528
    [No Abstract]   [Full Text] [Related]  

  • 3. Problems in the management of penicillin-resistant pneumococci.
    Boswell TC; Smith EG; Ayres JG
    J Hosp Infect; 1995 Jul; 30(3):233-5. PubMed ID: 8522781
    [No Abstract]   [Full Text] [Related]  

  • 4. [Decreased penicillin sensitivity of pneumococci].
    Zbinden R
    Ther Umsch; 1998 Jan; 55(1):18-21. PubMed ID: 9492613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation is the weapon against resistant pneumococci].
    Filipsson A
    Lakartidningen; 1995 Apr; 92(14):1435. PubMed ID: 7707789
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic resistance. Epidemiology of resistance--respiratory tract infections.
    Thomson CJ
    J Med Microbiol; 1997 Jun; 46(6):442-5. PubMed ID: 9379469
    [No Abstract]   [Full Text] [Related]  

  • 7. Trends in antimicrobial resistance of Streptococcus pneumoniae in children in a Turkish hospital.
    Sener B; Günalp A
    J Antimicrob Chemother; 1998 Sep; 42(3):381-4. PubMed ID: 9786478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical impact of macrolide resistance in pneumococcal respiratory infections.
    Garau J
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S33-8. PubMed ID: 11574193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The microbiologist's point of view].
    Gutmann L
    Presse Med; 2002 Nov; 31(37 Pt 2):S4-5. PubMed ID: 12489324
    [No Abstract]   [Full Text] [Related]  

  • 10. The in vivo-in vitro paradox in pneumococcal respiratory tract infections.
    Bishai W
    J Antimicrob Chemother; 2002 Mar; 49(3):433-6. PubMed ID: 11864942
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic resistance patterns and serotype distribution in Streptococcus pneumoniae from hospitalized pediatric patients with respiratory infections in Suzhou, China.
    Chen R; Chen Y; Black S; Hao CL; Ding YF; Zhang T; Zhao GM
    J Trop Pediatr; 2010 Jun; 56(3):204-5. PubMed ID: 19748932
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacteriological aspects in the mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():91-5. PubMed ID: 12638153
    [No Abstract]   [Full Text] [Related]  

  • 13. [Discussions on PRSP and BLNAR].
    Tajima T; Meguro H; Akita H; Iwata T
    Jpn J Antibiot; 2001 May; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new antibiotic against respiratory tract infections. More power against pneumococci].
    MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of cefditoren against a special collection of clinical isolates of Streptococcus pneumoniae from Hungary.
    Nagy E; Marton A; Hajdú E
    Acta Microbiol Immunol Hung; 2003; 50(2-3):119-24. PubMed ID: 12894483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence and treatment for antibiotic-resistant bacteria in respiratory infection].
    Watanuki Y
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():502-7. PubMed ID: 17455671
    [No Abstract]   [Full Text] [Related]  

  • 17. The emergence of resistant pneumococcus as a pathogen in childhood upper respiratory tract infections.
    Kaplan SL
    Semin Respir Infect; 1995 Mar; 10(1):31-6. PubMed ID: 7761712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA).
    Mölstad S; Cars O
    Scand J Infect Dis; 1999; 31(2):191-5. PubMed ID: 10447331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolones and pneumococci.
    Tillotson GS; Peterson LR
    J Antimicrob Chemother; 2000 May; 45(5):709-10. PubMed ID: 10797099
    [No Abstract]   [Full Text] [Related]  

  • 20. [Increasing antibiotic resistance of pneumococcus. Management of respiratory tract infections and meningitis].
    Kalin M; Eriksson M; Mölstad S; Prellner K
    Lakartidningen; 1997 Mar; 94(12):1061-4, 1067-8. PubMed ID: 9121238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.